Previous Article | Next Article 
Infection and Immunity, May 2001, p. 2902-2908, Vol. 69, No. 5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.2902-2908.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Role of Helicobacter pylori cag Region
Genes in Colonization and Gastritis in Two Animal Models
Kathryn A.
Eaton,1,*
Dange
Kersulyte,2
Megan
Mefford,1
Stephen J.
Danon,1,
Steven
Krakowka,1 and
Douglas
E.
Berg2
Department of Veterinary Biosciences, Ohio
State University, Columbus, Ohio 43210,1 and
Department of Molecular Microbiology, Washington University
School of Medicine, St. Louis, Missouri 63110-10932
Received 4 December 2000/Returned for modification 19 January
2001/Accepted 7 February 2001
 |
ABSTRACT |
The Helicobacter pylori chromosomal region known as the
cytotoxin-gene associated pathogenicity island (cag PAI) is
associated with severe disease and encodes proteins that are believed
to induce interleukin (IL-8) secretion by cultured epithelial cells. The objective of this study was to evaluate the relationship between the cag PAI, induction of IL-8, and induction of
neutrophilic gastric inflammation. Germ-free neonatal piglets and
conventional C57BL/6 mice were given wild-type or cag
deficient mutant derivatives of H. pylori strain 26695 or
SS1. Bacterial colonization was determined by plate count, gastritis
and neutrophilic inflammation were quantified, and IL-8 induction in
AGS cells was determined by enzyme-linked immunosorbent assay. Deletion
of the entire cag region or interruption of the
virB10 or virB11 homolog had no effect on
bacterial colonization, gastritis, or neutrophilic inflammation. In
contrast, these mutations had variable effects on IL-8 induction,
depending on the H. pylori strain. In the piglet-adapated
strain 26695, which induced IL-8 secretion by AGS cells, deletion of
the cag PAI decreased induction. In the mouse-adapted
strain SS1, which did not induce IL-8 secretion, deletion of the
cagII region or interruption of any of three
cag region genes increased IL-8 induction. These results
indicate that in mice and piglets (i) neither the cag PAI
nor the ability to induce IL-8 in vitro is essential for colonization
or neutrophilic inflammation and (ii) there is no direct relationship
between the presence of the cag PAI, IL-8 induction, and
neutrophilic gastritis.
 |
INTRODUCTION |
The gastric bacterium
Helicobacter pylori, first cultured in 1983, is now a
well-established cause of gastritis and peptic ulcer disease (22,
41). Infection is associated with production of proinflammatory
cytokines which lead to chronic or chronic active gastritis. The
activity of the gastritis (i.e., the intensity of neutrophil influx) is
commonly considered an indicator of severity, and chronic active
gastritis is associated with more severe manifestations of disease,
such as peptic ulceration and neoplasia (9, 14, 47).
Among the cytokines associated with H. pylori colonization,
the CXC family of chemokines may be involved in inducing neutrophilic influx. Two of these CXC chemokines and neutrophil chemoattractants, interleukin-8 (IL-8) and GRO-
, are increased in the gastric mucosa of patients with chronic active gastritis and ulceration (14-16, 18, 47, 53, 54, 56, 61). In addition, coculture of H. pylori with gastric cancer cell lines (15, 32, 52),
normal human gastric mucosal cells (44), and immortalized
mouse gastric mucus cells (40) results in induction of
proinflammatory cytokines IL-8 and IL-6 or, in murine cells, CINC-2
,
the rodent equivalent of GRO-
. In vivo, IL-8 secretion is most
prominent in the superficial gastric mucosa (18), and it
is likely that mucosal epithelial cells are a source of
neutrophil-inducing cytokines, although other sources likely exist
(10, 26, 34, 62). Thus, it is commonly supposed that
severe manifestations of H. pylori-related disease are
promoted by H. pylori-induced epithelial secretion of IL-8
and the attendant neutrophilic inflammation.
H. pylori-induced chemokine secretion by gastric epithelial
cells appears to be facilitated at least in part by genes in the cag pathogenicity island (PAI). This stretch of
approximately 30 open reading frames is present in many but not all
strains of H. pylori, and many of the predicted genes are
homologous to virulence-associated genes of other bacterial pathogens
(2, 11, 12). Homology to the vir genes of
Agrobacterium tumefaciens and the ptl genes of
Bordetella pertussis suggests that H. pylori cag
PAI genes may code for a type IV secretion complex important in
delivery of proinflammatory or other pathogenic molecules to host cells
(12, 43).
In addition to genetic homologies, there is functional evidence of the
role of the cag PAI in virulence. Its presence is associated with increased severity of disease in the human host (9,
47). In addition, induction of IL-8 in cultured cells in vitro
appears to depend at least in part on cag genes, at least in
some H. pylori strains (2, 11). In spite of
genetic, epidemiologic, and in vitro evidence supporting the link
between cag genes, IL-8 induction in vitro, and neutrophilic
gastric inflammation, however, few animal model studies have been done
to investigate the role of cag PAI genes in vivo.
The goal of this study was to use two animal models to evaluate both
the cag PAI as a whole and selected cag PAI genes
in induction of gastritis in vivo. The germ-free piglet model of infection uses strain 26695, a pig-adapted human isolate
(23). Strain 26695 colonizes piglets well and induces
gastritis which is largely lymphocytic and lymphofollicular, with a
variable neutrophilic component. Strain 26695 induces IL-8 in vitro
(2, 38), its genomic DNA sequence is known
(57), and its cag PAI is uninterrupted (the
cagI and cagII regions are adjacent), allowing
deletion of the entire region by simple reverse genetics
(2). Mice are poorly colonized by strain 26695 but are
well colonized by strain SS1, the other strain used in this study
(24, 37).
 |
MATERIALS AND METHODS |
Bacterial strains.
Strain 26695 is a human isolate which was
adapted to pig colonization by serial passage (3). Strain
SS1 is a mouse-adapted human isolate (37). Both strains
contain the cag PAI, which is continuous in 26695 (2) but divided into cagI and cagII in SS1 as described for other H. pylori strains
(2). Construction of mutant strains by transformation was
performed as previously described (2). The mutated genes
were HP0524, HP0525, and HP0527 (57). These genes are
located in the cagII region of the cag PAI and
have previously been referred to as cag10, cag11,
and cag13 (2). They are homologous to A. tumefaciens virD4, virB11, and virB10, respectively. In
A. tumefaciens, these genes code for proteins which form
part of a type IV secretion apparatus, and they are presumed to have a
similar function in H. pylori (12, 43). Their
presence has been associated with tyrosine phosphorylation of host and
bacterial proteins (4, 38, 43, 50, 55) as well as
secretion of IL-8 (15) upon contact with cultured cells.
The genetic constructs used have been previously described
(2). To inactivate individual genes, H. pylori
strain SS1 or 26695 was transformed with a DNA construct containing a
chloramphenicol resistence cassette (cat) inserted into the
coding region of the gene to be interrupted. To delete either
cagII or the entire cag region, strain SS1 or
26695 was transformed with a DNA construct containing cag
flanking sequences surrounding a chloramphenicol resistance cassette.
Gastritis and colonization potential of bacterial mutants were
evaluated in germ-free piglets inoculated with 26695 or
26695
cag and in mice given SS1,
SS1virB11::cat, or
SS1virB10::cat.
IL-8 assay.
IL-8 induction by H. pylori
cocultured with AGS cells was determined by the method of Crabtree et
al. (15). Briefly, AGS cells (a gastric carcinoma cell
line) were grown in 24-well plates to 60 to 75% confluence in RPMI
1640 supplemented with fetal calf serum. Broth-cultured H. pylori was washed in RPMI 1640 and resuspended to
107/ml, and 1 ml of the suspension was added to AGS cell
monolayers. After incubation for 24 h at 37°C, media were
collected, bacteria were removed by centrifugation, and media were
stored at
70°C until assay. IL-8 was detected with a capture
enzyme-linked immunosorbent assay kit (Pharmingen) according to the
manufacturer's instructions. Values reported were normalized by
subtraction of endogenous IL-8 production (production by unstimulated
AGS cells). Specificity of the assay was verified by inhibition with 1 µg of recombinant human IL-8 per ml.
Animal studies.
Germ-free piglets were derived and
maintained as previously described (23). They were orally
inoculated with 109 CFU of broth-cultured H. pylori at 3 days of age and killed 2, 7, or 14 days after
inoculation. Female 6 to 8-week-old helicobacter-free C57BL/6 mice
(from Jackson Laboratory) were maintained in microisolator cages and
fed sterile lab chow and water ad libitum. They were orally inoculated
with 107 CFU of broth-cultured H. pylori and
killed 3 or 13 weeks after inoculation. The number of animals in each
sacrifice group is given in Table 1.
At sacrifice, stomachs were removed and bisected along the greater and
lesser curvatures, and bacterial colonization in one half of the
stomach was quantified by plate dilution on blood agar plates with and
without 20 µg of chloramphenicol per ml. Sections of piglet stomach
from cardia, fundus, and antrum were formalin fixed and paraffin
embedded for histologic examination. Mouse stomach was sectioned in
approximately 1-mm-wide slices and then fixed and embedded as described above.
Immunohistochemistry.
Gastric sections from piglets killed 7 days after inoculation were examined for the presence of cells bearing
CD4 and CD8 surface markers. OCT-embedded frozen tissue was cut in
3-µm sections and stained as previously described (25).
Primary antibody (mouse monoclonal anti-pig CD4 or CD8; VMRL, Inc.,
Pullman, Wash.) was diluted 1:100. In control slides, normal mouse
serum was substituted for the primary antibody. Sections were scored by
enumerating the number of cells per 20× field. For each tissue block,
replicate sections stained for CD4 and CD8 were examined to identify
fields which were present in both slides. Of these, 6 to 12 fields
which contained CD4+ or CD8+ cells were
selected and scored. All sections were scored blind without knowledge
of their source or antibody stain.
Histopathology.
Hematoxylin-and-eosin stained sections were
scored for the extent of gastritis as previously described
(24). Briefly, microscopic fields containing gastritis
severe enough to displace glands, and fields containing neutrophilic
infiltrate were enumerated and expressed as a percentage of the gastric
mucosa. All available fields were scored, and slides were examined
blind, without knowledge of their source.
Statistics.
Means were compared by t-test or by
Mann-Whitney U test. Statistical significance was set at
P < 0.05.
 |
RESULTS |
Induction of IL-8 in AGS cells.
Strain 26695 induced IL-8
secretion when cocultured for 24 h with AGS cells, and deletion of the
cag PAI in this strain significantly decreased IL-8
induction to about 20% of the wild-type level (P = 0.02 [Fig. 1]). In contrast to
26695, and despite the presence of the cag PAI, wild-type
strain SS1 did not induce IL-8 secretion by AGS cells. IL-8 induction
by SS1 was 3% of induction by 26695 (P = 0.02) and not
significantly different from background (P = 0.25).
Interestingly, however, deletion of the entire cagII region
as well as any of the cag genes tested, the
virB10, virB11, and virD4 homologues,
resulted in slightly increased IL-8 induction by this strain. These
differences were consistent among all mutants, and IL-8 induction by
all mutant groups combined was significantly greater than induction by
wild-type SS1 (P = 0.009 [Fig. 1]).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Induction of IL-8 by H. pylori strains 26695, SS1, and cag-deficient mutants. *, significantly different
from isogenic mutants, P < 0.05; , significantly
different from strain 26695, P < 0.05.
|
|
Bacterial colonization.
Colonization rates were similar in
piglets (Fig. 2) and mice (Fig.
3). In both species, all inoculated
animals became colonized with all challenge strains, and the extent of
colonization ranged from approximately 105 to
108 CFU/g of gastric mucosa. In piglets, colonization by
26695 decreased over time from greater than 108 CFU/g of
gastric mucosa 2 days after inoculation to 4 × 106
CFU/g by 14 days after inoculation. In mice, colonization increased somewhat between 3 and 13 weeks after inoculation. Overall, there was
no consistent difference in colonization between wild-type and mutant
bacteria. Two days after inoculation, extent of colonization by
26695
cag was lower than that by 26695, but the difference did not persist to the other sacrifice intervals. Colonization by SS1,
SS1 virB11::cat, and
SS1virB10::cat differed somewhat from
each other, but there were no statistically significant differences.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Colonization of piglets by H. pylori strain
26695 and cag-deficient mutants 2, 7, and 14 days
postinoculation (PI). Two days after inoculation, colonization by
26695 cag was significantly less than colonization by
26695 (*, P < 0.05), but the two strains did not
differ at the other sacrifice intervals.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Colonization of mice by H. pylori strain SS1,
and cag-deficient mutants 3 and 13 weeks postinoculation
(PI). Colonization ranged from approximately 106 to
107 CFU/g of gastric mucosa, but there were no significant
differences between strains or sacrifice intervals.
|
|
Gastritis.
In piglets, gastritis was present 7 and 14 days
after inoculation (P = 0.01 and 0.021 compared to
uninfected piglets [Fig. 4]). It was
characterized primarily by lymphocytic and plasmacytic infiltrate (Fig.
5); neutrophilic infiltrate was variable
and mild (Fig. 4). In mice, gastritis was present 13 weeks after
inoculation (P = 0.0015, SS1-infected compared to
uninfected mice [Fig. 6]) and was
characterized by mixed inflammatory infiltrate including lymphocytes,
macrophages, plasma cells, and neutrophils as well as multifocal loss
of fundic gland morphology with replacement by mucus-type glands
(metaplasia) (Fig. 7). Neutrophilic
infiltrate was significantly elevated in these mice (P = 0.005, SS1 infected compared to uninfected), and was more
prominent than in piglets. In both mice and piglets there was no
difference in gastritis or neutrophilic infiltrate between groups
infected with wild-type H. pylori and groups infected with
cag mutant strains.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
Gastritis and neutrophilic infiltration (PMN) in piglets
colonized by H. pylori strain 26695 and
cag-deficient mutants 2, 7, and 14 days postinoculation
(PI). Seven and 14 days after inoculation gastritis was significantly
greater than in uninfected piglets (*, P < 0.05),
but there were no differences between strains.
|
|

View larger version (132K):
[in this window]
[in a new window]
|
FIG. 5.
Tissue from the gastric cardia of an uninfected
gnotobiotic piglet (A) and a piglet infected with H. pylori
strain 26695 for 14 days (B). Gastritis is characterized by lymphocytes
and plasma cells (arrowheads) with scattered neutrophils (arrow).
Hematoxylin and eosin stain. Bar = 75 µm.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 6.
Gastritis, neutrophilic infiltration (PMN), and
epithelial metaplasia in mice colonized by H. pylori strain
SS1 and cag-deficient mutants 3 and 13 weeks postinoculation
(PI). Three weeks after inoculation, neutrophilic inflammation was more
prominent in mice colonized by the cag-deficient mutants
than in mice colonized by SS1 ( , P < 0.05), but this
difference did not persist. Thirteen weeks after inoculation, PMN,
gastritis, and metaplasia were all significantly elevated in all mice
(*, P < 0.05), but there were no differences between
bacterial strains.
|
|

View larger version (101K):
[in this window]
[in a new window]
|
FIG. 7.
Tissue from the gastric fundus of an uninfected mouse
(A) and a mouse infected with H. pylori strain SS1 for 13 weeks (B). Gastritis is characterized by a mixed infiltrate of
lymphocytes and neutrophils. Note the paucity of parietal and chief
cells characteristic of epithelial metaplasia in H. pylori-infected mice (see reference 24). The arrows
indicate three remaining parietal cells. Hematoxylin and eosin stain.
Bar = 50 µm.
|
|
Immunohistochemistry.
Both CD4+ and
CD8+ cells were significantly increased in the gastric
mucosa of infected piglets compared to uninfected piglets (P < 0.05 [Table 2]). However, both
cell types were present in all infected piglets, and there were no
differences between piglets given 26695 and those given
26695
cag. In all piglets, more gastric lamina propria
lmphocytes expressed CD8 than CD4 (Table 2).
 |
DISCUSSION |
The results reported here seem to contradict current dogma in two
ways. First, we have shown that in at least one strain of H. pylori, SS1, the ability to induce IL-8 secretion by cultured gastric epithelial cells is not directly correlated with the presence of a cag-PAI. In contrast to strain 26695, strain SS1 did
not induce IL-8 secretion despite the presence of the PAI, and,
surprisingly, inactivation of several genes in that region actually
promoted, rather than inhibited, IL-8 induction. While these finding
contrast with many published studies (1, 11, 17, 19, 27, 38, 44,
58), they may actually represent an accurate assessment of the
phenotypic diversity of H. pylori. Most published studies used only one or a few well-characterized strains to demonstrate dependence of IL-8 secretion on the cag PAI. Recently
published studies, however, suggest that over a broad range of strains, IL-8 induction may not always correlate with presence or absence of the
cag PAI. In one study in which 80 clinical isolates were examined, IL-8 induction by cag-positive strains varied
widely, and some cag-negative strains were able to induce
IL-8 in cultured cells (61). In another study, 153 clinical isolates were examined, and in many cases strains with the
cag PAI failed to induce IL-8, while strains without the PAI
did induce secretion (7). A third study failed to find
either an association between IL-8 induction and cag or an
association between in vivo IL-8 levels and in vitro IL-8 induction by
the same strain (45). In addition,
non-cag-containing bacterial species other than H. pylori have been shown to induce IL-8 in cultured cells in some
studies (31). Finally, several H. pylori genes
unrelated to cag have been associated with IL-8 induction.
In one study cited above, IL-8 induction was partly dependent on
oipA, a gene which is unrelated to cag
(61). In other studies IL-8 induction has been associated
with flagellar morphology (46), heat shock proteins
(60), and other H. pylori products
(21).
Our demonstration that inactivation of cag genes leads to
promotion of IL-8 induction in SS1 has not been previously reported. However, this finding may be explained by diversity in secretory function as reported for other bacterial species. The cag
genes examined are presumed to encode part of a type IV secretion
system involved in injection of bacterial proteins into the host cell (12, 43, 55), and it is widely assumed that this secretion function is exclusively proinflammatory (1, 27, 51).
However, other bacterial species possess secretion systems which can
induce either proinflammatory or anti-inflammatory signals to host
cells (42, 59). It has been suggested, in fact, that
secretion of anti-inflammatory signals may be one way in which
nonpathogenic enteric bacteria down-regulate a host immune response.
Conceivably, an equivalent mechanism in H. pylori
contributes to the virulence of specific strains. That is, the
cag-related secretion system may function to deliver anti-
as well as proinflammatory signals to target tissues, thereby
determining in part the level of the host response.
A second surprising finding of this study was the lack of congruence
between IL-8 induction in vitro and neutrophilic gastritis in vivo in
mice. It is widely assumed that IL-8 induction in gastric epithelial
cells is the mechanism whereby neutrophilic gastritis is induced by
H. pylori. However, this hypothesis has not been tested in
animal models. In humans, IL-8 and neutrophils are both present in
gastric mucosa colonized by H. pylori (18, 47). The presumption of causation is based on two types of studies, the in
vitro induction of IL-8 by H. pylori and the epidemiologic association between cag-containing strains and disease.
The relationship between in vivo studies in cultured cells and in vivo
pathogenesis must be interpreted with caution. Gastric cancer cell
lines used for in vitro assays differ from gastric surface mucus cells
in many ways, including surface markers and receptors, lack of
polarity, and synthetic capability. Thus, their interactions with
bacteria are likely to differ. Even freshly isolated gastric epithelial
cells may not reflect in vivo conditions, since these cells are
mixtures of parietal cells, chief cells, neck cells, and surface mucus
cells. Only a minority of cells may be of the same phenotype and
response to H. pylori as the surface mucus cells that
encounter H. pylori in vivo. Another critical difference
between in vivo and in vitro interactions between H. pylori
and gastric epithelial cells is the multiplicity of infection. Cell
culture studies typically use ratios of 50 to 100 bacteria per gastric
epithelial cell, several orders of magnitude greater than the ratio
found in vivo (105 to 106 CFU/biopsy or more
than 10 epithelial cells to one bacterium) (6). Further,
bacteria in vitro surround and closely adhere to the gastric epithelial
cells in the absence of intervening mucus. In vivo, bacteria are mostly
within the mucus, a minority of bacteria actually adhere to the
epithelial cells, and those only adhere to the luminal surface. Thus,
interactions between bacteria and epithelial cells in vivo and in vitro
are likely to differ markedly, and induction of IL-8 synthesis by
bacterial contact in vitro does not necessarily indicate that such
induction occurs in vivo or is of sufficient magnitude to have a
primary effect.
Epidemiologic studies provide stronger evidence of an association
between cagA or the cag PAI and increased
severity of disease. Many such studies are published (for recent
reviews, see references 5 and 13), and most indicate that the
cag PAI has a role in the pathogenicity of H. pylori. However, the epidemiologic association between
cag and disease is not absolute, suggesting that the
relationship is likely not direct. Not all published studies have shown
a relationship between the cag PAI and increased severity of
disease (8, 28, 29, 35, 36, 39, 48, 63), and no study has
shown an absolute relationship. Even when there is an overall
statistical association between infection by strains which express
cag and increased severity of disease, many patients
examined have severe disease but were colonized by
cag-negative strains (28, 30, 33). Thus,
although the cag PAI clearly contributes to disease due to
H. pylori, cag-negative strains can also be pathogenic.
Taken together, the occurrence of cag-negative disease in
humans and the absence of an effect of cag in animal models
are most easily explained by the role of the host response in disease outcome. Data are accumulating that in both humans and experimental animals, the outcome of H. pylori-related disease is
strongly dependent on host immune response (20, 49).
Different hosts may differ in their response to H. pylori
antigens, thus leading to different outcomes in individuals infected
with strains of similar antigenicity. Greater antigenicity of
cag-dependent antigens in some individual hosts, host
strains, or host species could explain the tendency toward greater
pathogenicity of these strains. Clearly, however,
cag-independent antigens can induce disease, at least in
animals, and cag-negative strains are not necessarily innocuous.
 |
ACKNOWLEDGMENTS |
This work was supported in part by PHS grants NIH R01 AI43643,
R29 DK-45340, and R01 CA67498-01 from the NIH (Eaton) and by PHS grants
NIH R01 AI43643, AI38166, R29 DK-45340, DK53727, P30 DK52574, and R01
CA67498-01 from the NIH (Berg).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Veterinary Biosciences, Ohio State University, Columbus, OH 43210. Phone: (614) 292-9667. Fax: (614) 292-6473. E-mail:
eaton.1{at}osu.edu.
Present address: Microbiology and Immunology, University of New
South Wales, Kensington, NSW, Australia, 2033.
Editor:
J. T. Barbieri
 |
REFERENCES |
| 1.
|
Aihara, M.,
D. Tsuchimoto,
H. Takizawa,
A. Azuma,
H. Wakebe,
Y. Ohmoto,
K. Imagawa,
M. Kikuchi,
N. Mukaida, and K. Matsushima.
1997.
Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45.
Infect. Immun.
65:3218-3224[Abstract].
|
| 2.
|
Akopyants, N. S.,
S. W. Clifton,
D. Kersulyte,
J. E. Crabtree,
B. E. Youree,
C. A. Reece,
N. O. Bukanov,
E. S. Drazek,
B. A. Roe, and D. E. Berg.
1998.
Analyses of the cag pathogenicity island of Helicobacter pylori.
Mol. Microbiol.
28:37-53[CrossRef][Medline].
|
| 3.
|
Akopyants, N. S.,
K. A. Eaton, and D. E. Berg.
1995.
Adaptive mutation and cocolonization during Helicobacter pylori infection of gnotobiotic piglets.
Infect. Immun.
63:116-121[Abstract].
|
| 4.
|
Asahi, M.,
T. Azuma,
S. Ito,
Y. Ito,
H. Suto,
Y. Nagai,
M. Tsubokawa,
Y. Tohyama,
S. Maeda,
M. Omata,
T. Suzuki, and C. Sasakawa.
2000.
Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells.
J. Exp. Med.
191:593-602[Abstract/Free Full Text].
|
| 5.
|
Atherton, J. C.
1999.
CagA, the cag pathogenicity island and Helicobacter pylori virulence.
Gut
44:307-308[Free Full Text].
|
| 6.
|
Atherton, J. C.,
K. T. Tham,
R. M. Peek,
T. L. Cover, and M. J. Blaser.
1996.
Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology.
J. Infect. Dis.
174:552-556[Medline].
|
| 7.
|
Audibert, C.,
B. Burucoa,
B. Janvier, and J. L. Fauchere.
2000.
Structure of the cag pathogenicity island of 153 French isolates of Helicobacter pylori and correlation with the IL-8 in vitro induction
Gut
47:A30. (Abstract.)
|
| 8.
|
Bach, S.,
A. Makristathis,
A. Pinto,
M. Quina,
M. Rotter, and A. M. Hirschl.
1999.
Helicobacter pylori type I strains among Austrian and Portuguese patients with gastritis, peptic ulcer or gastric cancer.
Eur. J. Clin. Microbiol. Infect. Dis.
18:807-810[CrossRef][Medline].
|
| 9.
|
Blaser, M. J.,
G. I. Perezperez,
H. Kleanthous,
T. L. Cover,
R. M. Peek,
P. H. Chyou,
G. N. Stemmermann, and A. Nomura.
1995.
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.
Cancer Res.
55:2111-2115[Abstract/Free Full Text].
|
| 10.
|
Bliss, C. M.,
D. T. Golenbock,
S. Keates,
J. K. Linevsky, and C. P. Kelly.
1998.
Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes.
Infect. Immun.
66:5357-5363[Abstract/Free Full Text].
|
| 11.
|
Censini, S.,
C. Lange,
Z. Xiang,
J. E. Crabtree,
P. Ghiara,
M. Borodovsky,
R. Rappuoli, and A. Covacci.
1996.
cag, a pathogenicity island of Helicobacter pylori, encodes type-I specific and disease-associated virulence factors.
Proc. Natl. Acad. Sci. USA
93:14648-14654[Abstract/Free Full Text].
|
| 12.
|
Covacci, A.,
J. Telford,
G. G. Del,
J. Parsonnet, and R. Rappuoli.
1999.
Helicobacter pylori virulence and genetic geography.
Science
284:1328-1333[Abstract/Free Full Text].
|
| 13.
|
Cover, T. L., and M. J. Blaser.
1999.
Helicobacter pylori factors associated with disease.
Gastroenterology
117:257-260[CrossRef][Medline].
|
| 14.
|
Crabtree, J. E.
1998.
Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage.
Dig. Dis. Sci.
43:S46-S55.
|
| 15.
|
Crabtree, J. E.,
A. Covacci,
S. M. Farmery,
Z. Xiang,
D. S. Tompkins,
S. Perry,
I. J. D. Lindley, and R. Rappuoli.
1995.
Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.
J. Clin. Pathol.
48:41-45[Abstract/Free Full Text].
|
| 16.
|
Crabtree, J. E., and S. M. Farmery.
1995.
Helicobacter pylori and gastric mucosal cytokines: evidence that CagA-positive strains are more virulent.
Lab. Investig.
73:742-745[Medline].
|
| 17.
|
Crabtree, J. E.,
D. Kersulyte,
S. D. D. Li,
I. J. D. Lindley, and D. E. Berg.
1999.
Modulation of Helicobacter pylori induced interleukin-8 synthesis in gastric epithelial cells mediated by cag PAI encoded VirD4 homologue.
J. Clin. Pathol.
52:653-657[Abstract].
|
| 18.
|
Crabtree, J. E.,
J. I. Wyatt,
L. K. Trejdosiewicz,
P. Peichl,
P. H. Nichols,
N. Ramsay,
J. N. Primrose, and I. J. Lindley.
1994.
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa.
J. Clin. Pathol.
47:61-66[Abstract/Free Full Text].
|
| 19.
|
Crabtree, J. E.,
Z. Xiang,
I. J. Lindley,
D. S. Tompkins,
R. Rappuoli, and A. Covacci.
1995.
Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori.
J. Clin. Pathol.
48:967-969[Abstract/Free Full Text].
|
| 20.
|
D'Elios, M. M.,
M. Manghetti,
F. Almerigogna,
A. Amedei,
F. Costa,
D. Burroni,
C. T. Baldari,
S. Romagnani,
J. L. Telford, and G. Delprete.
1997.
Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer.
Eur. J. Immunol.
27:1751-1755[Medline].
|
| 21.
|
Ding, S. Z.,
C. H. Cho, and S. K. Lam.
1997.
Helicobacter pylori induces interleukin-8 expression in endothelial cells and the signal pathway is protein tyrosine kinase dependent.
Biochem. Biophys. Res. Commun.
240:561-565[CrossRef][Medline].
|
| 22.
|
Dunn, B. E.,
H. Cohen, and M. J. Blaser.
1997.
Helicobacter pylori.
Clin. Microbiol. Rev.
10:720-741[Abstract].
|
| 23.
|
Eaton, K. A.,
D. R. Morgan, and S. Krakowka.
1989.
Campylobacter pylori virulence factors in gnotobiotic piglets.
Infect. Immun.
57:1119-1125[Abstract/Free Full Text].
|
| 24.
|
Eaton, K. A.,
S. R. Ringler, and S. J. Danon.
1999.
Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice.
Infect. Immun.
67:4594-4602[Abstract/Free Full Text].
|
| 25.
|
Eaton, K. A.,
S. S. Ringler, and S. Krakowka.
1998.
Vaccination of gnotobiotic piglets against Helicobacter pylori.
J. Infect. Dis.
178:1399-1405[CrossRef][Medline].
|
| 26.
|
Evans, D. J.,
D. G. Evans,
T. Takemura,
H. Nakano,
H. C. Lampert,
D. Y. Graham,
D. N. Granger, and P. R. Kvietys.
1995.
Characterization of a Helicobacter pylori neutrophil-activating protein.
Infect. Immun.
63:2213-2220[Abstract].
|
| 27.
|
Glocker, E.,
C. Lange,
A. Covacci,
S. Bereswill,
M. Kist, and H. L. Pahl.
1998.
Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF- B activation.
Infect. Immun.
66:2346-2348[Abstract/Free Full Text].
|
| 28.
|
Go, M. F., and D. Y. Graham.
1996.
Presence of the cagA gene in the majority of Helicobacter pylori strains is independent of whether the individual has duodenal ulcer or asymptomatic gastritis.
Helicobacter
1:107-111[Medline].
|
| 29.
|
Graham, D. Y.,
R. M. Genta,
D. P. Graham, and J. E. Crabtree.
1996.
Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.
J. Clin. Pathol.
49:829-832[Abstract/Free Full Text].
|
| 30.
|
Heikkinen, M.,
E. Janatuinen,
K. Mayo,
F. Megraud,
R. Julkunen, and P. Pikkarainen.
1997.
Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy.
Am. J. Gastroenterol.
92:2225-2229[Medline].
|
| 31.
|
Hickey, T. E.,
S. Baqar,
A. L. Bourgeois,
C. P. Ewing, and P. Guerry.
1999.
Campylobacter jejuni-stimulated secretion of interleukin-8 by INT407 cells.
Infect. Immun.
67:88-93[Abstract/Free Full Text].
|
| 32.
|
Huang, J. Z.,
P. W. Otoole,
P. Doig, and T. J. Trust.
1995.
Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori.
Infect. Immun.
63:1732-1738[Abstract].
|
| 33.
|
Jenks, P. J.,
F. Megraud, and A. Labigne.
1998.
Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island.
Gut
43:752-758[Abstract/Free Full Text].
|
| 34.
|
Kim, J. S.,
H. C. Jung,
J. M. Kim,
I. S. Song, and C. Y. Kim.
1998.
Interleukin-8 expression by human neutrophils activated by Helicobacter pylori soluble proteins.
Scand. J. Gastroenterol.
33:1249-1255[CrossRef][Medline].
|
| 35.
|
Kodama, K.,
A. Ito,
A. Nishizono,
T. Fujioka,
M. Nasu,
K. Yahiro,
T. Hirayama, and N. Uemura.
1999.
Divergence of virulence factors of Helicobacter pylori among clinical isolates does not correlate with disease specificity.
J. Gastroenterol.
34(Suppl. 11):6-9.
|
| 36.
|
Kurihara, N.,
S. Kamiya,
H. Yamaguchi,
T. Osaki,
H. Shinohara,
T. Kitahora,
H. Ishida,
A. Ozawa,
Y. Otani,
T. Kubota,
K. Kumai, and M. Kitajima.
1998.
Characteristics of Helicobacter pylori strains isolated from patients with different gastric diseases.
J. Gastroenterol.
33(Suppl. 10):10-13.
|
| 37.
|
Lee, A.,
J. Orourke,
M. C. Deungria,
B. Robertson,
G. Daskalopoulos, and M. F. Dixon.
1997.
A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain.
Gastroenterology
112:1386-1397[CrossRef][Medline].
|
| 38.
|
Li, S.,
D. Kersulyte,
I. Lindley,
B. Neelam,
D. Berg, and J. Crabtree.
1999.
Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells.
Infect. Immun.
67:3893-3899[Abstract/Free Full Text].
|
| 39.
|
Maeda, S.,
F. Kanai,
K. Ogura,
H. Yoshida,
T. Ikenoue,
M. Takahashi,
T. Kawabe,
Y. Shiratori, and M. Omata.
1997.
High seropositivity of anti-CagA antibody in Helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan.
Dig. Dis. Sci.
42:1841-1847[CrossRef][Medline].
|
| 40.
|
Maekawa, T.,
Y. Kinoshita,
Y. Matsushima,
A. Okada,
H. Fukui,
S. Waki,
K. Kishi,
C. Kawanami,
H. Nakata,
S. Hassan,
Y. Wakatsuki,
H. Ota,
K. Amano,
M. Nakao, and T. Chiba.
1997.
Helicobacter pylori induces proinflammatory cytokines and major histocompatibility complex class II antigen in mouse gastric epithelial cells.
J. Lab. Clin. Med.
130:442-449[CrossRef][Medline].
|
| 41.
|
Marshall, B. J., and J. R. Warren.
1984.
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.
Lancet
i:1311-1315.
|
| 42.
|
Neish, A. S.,
A. T. Gewirtz,
H. Zeng,
A. N. Young,
M. E. Hobert,
V. Karmali,
A. S. Rao, and J. L. Madara.
2000.
Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.
Science
289:1560-1563[Abstract/Free Full Text].
|
| 43.
|
Odenbreit, S.,
J. Puls,
B. Sedlmaier,
E. Gerland,
W. Fischer, and R. Haas.
2000.
Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion.
Science
287:1497-1500[Abstract/Free Full Text].
|
| 44.
|
Ogura, K.,
M. Takahashi,
S. Maeda,
T. Ikenoue,
F. Kanai,
H. Yoshida,
Y. Shiratori,
K. Mori,
K. I. Mafune, and M. Omata.
1998.
Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori.
Dig. Dis. Sci.
43:2738-2743[CrossRef][Medline].
|
| 45.
|
Ohsuga, M.,
K. Kusugami,
K. Ina,
T. Ando,
H. Yamaguchi,
A. Imada,
Y. Nishio,
M. Shimada,
T. Tsuzuki,
M. Noshiro,
T. Konagaya, and H. Kaneko.
2000.
Comparison between in vivo and in vitro chemokine production in Helicobacter pylori infection.
Aliment. Pharmacol. Ther.
14(Suppl. 1)1:205-215.
|
| 46.
|
Ohta-Tada, U.,
A. Takagi,
Y. Koga,
S. Kamiya, and T. Miwa.
1997.
Flagellin gene diversity among Helicobacter pylori strains and IL-8 secretion from gastric epithelial cells.
Scand. J. Gastroenterol.
32:455-459[Medline].
|
| 47.
|
Peek, R. M.,
G. G. Miller,
K. T. Tham,
G. I. Perezperez,
X. M. Zhao,
J. C. Atherton, and M. J. Blaser.
1995.
Heightened inflammatory response and cytokine expression in vivo to cagA(+) Helicobacter pylori strains.
Lab. Investis.
73:760-770[Medline].
|
| 48.
|
Sadakane, Y.,
K. Kusaba,
Z. Nagasawa,
I. Tanabe,
S. Kuroki, and J. Tadano.
1999.
Prevalence and genetic diversity of cagD, cagE, and vacA in Helicobacter pylori strains isolated from Japanese patients.
Scand. J. Gastroenterol.
34:981-986[CrossRef][Medline].
|
| 49.
|
Sakagami, T.,
M. Dixon,
J. O'Rourke,
R. Howlett,
F. Alderuccio,
J. Vella,
T. Shimoyama, and A. Lee.
1996.
Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis.
Gut
39:639-648[Abstract/Free Full Text].
|
| 50.
|
Segal, E. D.,
J. Cha,
J. Lo,
S. Falkow, and L. S. Tompkins.
1999.
Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori.
Proc. Natl. Acad. Sci. USA
96:14559-14564[Abstract/Free Full Text].
|
| 51.
|
Sharma, S. A.,
M. K. R. Tummuru,
M. J. Blaser, and L. D. Kerr.
1998.
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells.
J. Immunol.
160:2401-2407[Abstract/Free Full Text].
|
| 52.
|
Sharma, S. A.,
M. K. R. Tummuru,
G. G. Miller, and M. J. Blaser.
1995.
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro.
Infect. Immun.
63:1681-1687[Abstract].
|
| 53.
|
Shimoyama, T., and J. E. Crabtree.
1997.
Mucosal chemokines in Helicobacter pylori infection.
J. Physiol. Pharmacol.
48:315-323[Medline].
|
| 54.
|
Shimoyama, T.,
S. M. Everett,
M. F. Dixon,
A. T. R. Axon, and J. E. Crabtree.
1998.
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis.
J. Clin. Pathol.
51:765-770[Abstract].
|
| 55.
|
Stein, M.,
R. Rappuoli, and A. Covacci.
2000.
Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation.
Proc. Natl. Acad. Sci. USA
97:1263-1268[Abstract/Free Full Text].
|
| 56.
|
Suzuki, H.,
M. Mori,
A. A. Sakaguchi,
M. Suzuki,
S. Miura, and H. Ishii.
1998.
Enhanced levels of C-X-C chemokine, human GRO alpha, in Helicobacter pylori-associated gastric disease.
J. Gastroenterol. Hepatol.
13:516-520[Medline].
|
| 57.
|
Tomb, J. F.,
O. White,
A. R. Kerlavage,
R. A. Clayton, et al.
1997.
The complete genome sequence of the gastric pathogen Helicobacter pylori.
Nature
388:539-547[CrossRef][Medline].
|
| 58.
|
Tummuru, M. K. R.,
S. A. Sharma, and M. J. Blaser.
1995.
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells.
Mol. Microbiol.
18:867-876[CrossRef][Medline].
|
| 59.
|
Xavier, R. J.,
D. K. Podolsky,
A. S. Neish,
A. T. Gewirtz,
H. Zeng,
A. N. Young,
M. E. Hobert,
V. Karmali,
A. S. Rao, and J. L. Madara.
2000.
Microbiology. How to get along friendly microbes in a hostile world.
Science
289:1483-1484[Free Full Text].
|
| 60.
|
Yamaguchi, H.,
T. Osaki,
N. Kurihara,
M. Kitajima,
M. Kai,
M. Takahashi,
H. Taguchi, and S. Kamiya.
1999.
Induction of secretion of interleukin-8 from human gastric epithelial cells by heat-shock protein 60 homologue of Helicobacter pylori.
J. Med. Microbiol.
48:927-933[Abstract].
|
| 61.
|
Yamaoka, Y.,
M. Kita,
T. Kodama,
N. Sawai, and J. Imanishi.
1996.
Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.
Gastroenterology
110:1744-1752[CrossRef][Medline].
|
| 62.
|
Yoshida, M.,
Y. Wakatsuki,
Y. Kobayashi,
T. Itoh,
K. Murakami,
A. Mizoguchi,
T. Usui,
T. Chiba, and T. Kita.
1999.
Cloning and characterization of a novel membrane-associated antigenic protein of Helicobacter pylori.
Infect. Immun.
67:286-293[Abstract/Free Full Text].
|
| 63.
|
Zheng, P. Y.,
J. Hua,
K. G. Yeoh, and B. Ho.
2000.
Jul. Association of peptic ulcer with increased expression of Lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population.
Gut
47:18-22[Abstract/Free Full Text].
|
Infection and Immunity, May 2001, p. 2902-2908, Vol. 69, No. 5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.2902-2908.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hisatsune, J., Nakayama, M., Isomoto, H., Kurazono, H., Mukaida, N., Mukhopadhyay, A. K., Azuma, T., Yamaoka, Y., Sap, J., Yamasaki, E., Yahiro, K., Moss, J., Hirayama, T.
(2008). Molecular Characterization of Helicobacter pylori VacA Induction of IL-8 in U937 Cells Reveals a Prominent Role for p38MAPK in Activating Transcription Factor-2, cAMP Response Element Binding Protein, and NF-{kappa}B Activation. J. Immunol.
180: 5017-5027
[Abstract]
[Full Text]
-
Ferrero, R. L., Ave, P., Ndiaye, D., Bambou, J.-C., Huerre, M. R., Philpott, D. J., Memet, S.
(2008). NF-{kappa}B Activation during Acute Helicobacter pylori Infection in Mice. Infect. Immun.
76: 551-561
[Abstract]
[Full Text]
-
Williams, S. M., Chen, Y.-T., Andermann, T. M., Carter, J. E., McGee, D. J., Ottemann, K. M.
(2007). Helicobacter pylori Chemotaxis Modulates Inflammation and Bacterium-Gastric Epithelium Interactions in Infected Mice. Infect. Immun.
75: 3747-3757
[Abstract]
[Full Text]
-
Baldwin, D. N., Shepherd, B., Kraemer, P., Hall, M. K., Sycuro, L. K., Pinto-Santini, D. M., Salama, N. R.
(2007). Identification of Helicobacter pylori Genes That Contribute to Stomach Colonization. Infect. Immun.
75: 1005-1016
[Abstract]
[Full Text]
-
Kundu, P., Mukhopadhyay, A. K., Patra, R., Banerjee, A., Berg, D. E., Swarnakar, S.
(2006). Cag Pathogenicity Island-independent Up-regulation of Matrix Metalloproteinases-9 and -2 Secretion and Expression in Mice by Helicobacter pylori Infection. J. Biol. Chem.
281: 34651-34662
[Abstract]
[Full Text]
-
Hilleringmann, M., Pansegrau, W., Doyle, M., Kaufman, S., MacKichan, M. L., Gianfaldoni, C., Ruggiero, P., Covacci, A.
(2006). Inhibitors of Helicobacter pylori ATPase Cag{alpha} block CagA transport and cag virulence.. Microbiology
152: 2919-2930
[Abstract]
[Full Text]
-
Kaparakis, M., Laurie, K. L., Wijburg, O., Pedersen, J., Pearse, M., van Driel, I. R., Gleeson, P. A., Strugnell, R. A.
(2006). CD4+ CD25+ Regulatory T Cells Modulate the T-Cell and Antibody Responses in Helicobacter-Infected BALB/c Mice.. Infect. Immun.
74: 3519-3529
[Abstract]
[Full Text]
-
van Amsterdam, K., Bart, A., van der Ende, A.
(2005). A Helicobacter pylori TolC Efflux Pump Confers Resistance to Metronidazole. Antimicrob. Agents Chemother.
49: 1477-1482
[Abstract]
[Full Text]
-
Yuan, J.-P., Li, T., Chen, H.-B., Li, Z.-H., Yang, G.-Z., Hu, B.-Y., Shi, X.-D., Tong, S.-Q., Li, Y.-X., Guo, X.-K.
(2004). Analysis of gene expression profile in gastric cancer cells stimulated with Helicobacter pylori isogenic strains. J Med Microbiol
53: 965-974
[Abstract]
[Full Text]
-
Dohi, T., Fujihashi, K., Koga, T., Etani, Y., Yoshino, N., Kawamura, Y. I., McGhee, J. R.
(2004). CD4+CD45RBHi Interleukin-4 Defective T Cells Elicit Antral Gastritis and Duodenitis. Am. J. Pathol.
165: 1257-1268
[Abstract]
[Full Text]
-
Clyne, M., Drumm, B.
(2004). Helicobacter pylori Infection of Human and Murine Primary Gastric Cells. Infect. Immun.
72: 5464-5469
[Abstract]
[Full Text]
-
Thompson, L. J., Danon, S. J., Wilson, J. E., O'Rourke, J. L., Salama, N. R., Falkow, S., Mitchell, H., Lee, A.
(2004). Chronic Helicobacter pylori Infection with Sydney Strain 1 and a Newly Identified Mouse-Adapted Strain (Sydney Strain 2000) in C57BL/6 and BALB/c Mice. Infect. Immun.
72: 4668-4679
[Abstract]
[Full Text]
-
Eaton, K. A., Logan, S. M., Baker, P. E., Peterson, R. A., Monteiro, M. A., Altman, E.
(2004). Helicobacter pylori with a Truncated Lipopolysaccharide O Chain Fails To Induce Gastritis in SCID Mice Injected with Splenocytes from Wild-Type C57BL/6J Mice. Infect. Immun.
72: 3925-3931
[Abstract]
[Full Text]
-
Backert, S., Schwarz, T., Miehlke, S., Kirsch, C., Sommer, C., Kwok, T., Gerhard, M., Goebel, U. B., Lehn, N., Koenig, W., Meyer, T. F.
(2004). Functional Analysis of the cag Pathogenicity Island in Helicobacter pylori Isolates from Patients with Gastritis, Peptic Ulcer, and Gastric Cancer. Infect. Immun.
72: 1043-1056
[Abstract]
[Full Text]
-
Hoffman, P. S., Vats, N., Hutchison, D., Butler, J., Chisholm, K., Sisson, G., Raudonikiene, A., Marshall, J. S., Veldhuyzen van Zanten, S. J. O.
(2003). Development of an Interleukin-12-Deficient Mouse Model That Is Permissive for Colonization by a Motile KE26695 Strain of Helicobacter pylori. Infect. Immun.
71: 2534-2541
[Abstract]
[Full Text]
-
McGEE, D. J., COKER, C., TESTERMAN, T. L., HARRO, J. M., GIBSON, S. V., MOBLEY, H. L. T.
(2002). The Helicobacter pylori flbA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J Med Microbiol
51: 958-970
[Abstract]
[Full Text]
-
Thalmaier, U., Lehn, N., Pfeffer, K., Stolte, M., Vieth, M., Schneider-Brachert, W.
(2002). Role of Tumor Necrosis Factor Alpha in Helicobacter pylori Gastritis in Tumor Necrosis Factor Receptor 1-Deficient Mice. Infect. Immun.
70: 3149-3155
[Abstract]
[Full Text]
-
Marchetti, M., Rappuoli, R.
(2002). Isogenic mutants of the cag pathogenicity island of Helicobacter pylori in the mouse model of infection: effects on colonization efficiency. Microbiology
148: 1447-1456
[Abstract]
[Full Text]
-
Selbach, M., Moese, S., Meyer, T. F., Backert, S.
(2002). Functional Analysis of the Helicobacter pylori cag Pathogenicity Island Reveals Both VirD4-CagA-Dependent and VirD4-CagA-Independent Mechanisms. Infect. Immun.
70: 665-671
[Abstract]
[Full Text]
-
Eaton, K. A., Gilbert, J. V., Joyce, E. A., Wanken, A. E., Thevenot, T., Baker, P., Plaut, A., Wright, A.
(2002). In Vivo Complementation of ureB Restores the Ability of Helicobacter pylori To Colonize. Infect. Immun.
70: 771-778
[Abstract]
[Full Text]
-
Bjorkholm, B., Lundin, A., Sillen, A., Guillemin, K., Salama, N., Rubio, C., Gordon, J. I., Falk, P., Engstrand, L.
(2001). Comparison of Genetic Divergence and Fitness between Two Subclones of Helicobacter pylori. Infect. Immun.
69: 7832-7838
[Abstract]
[Full Text]